AI Reads the Heart’s Forgotten Chamber to Predict Death and Disease

For decades, the right ventricle has been the awkward chamber of the heart — the one cardiologists squint at, measure inconsistently, and often describe in vague, qualitative terms. Now, a team from Mass General Brigham, Harvard Medical School and the Broad Institute of MIT and Harvard has built an artificial intelligence model that turns routine ultrasound videos into precise, quantitative measurements of right ventricular size and function, and then shows that those measurements forecast death, atrial fibrillation and heart failure. The study, published in Nature Cardiovascular Research, suggests that a chamber long relegated to the margins of cardiac imaging may deserve a central place in cardiovascular risk prediction.

The model, named DROID-RV — short for Dimensional Reconstruction of Imaging Data-Right Ventricle — was trained on an extraordinary volume of real-world clinical data: 17,141 ambulatory cardiology patients, spanning 51,188 echocardiographic studies and 383,881 individual video clips. Each of those clips captured the beating heart from the standard windows used in transthoracic echocardiography, the ubiquitous ultrasound scan performed millions of times a year worldwide. By learning from hundreds of thousands of labeled examples, DROID-RV absorbed the visual grammar of the right ventricle in a way no single human reader ever could.

Technically, the model is built on a MoViNet backbone, an efficient video-recognition neural network architecture originally designed for mobile video analysis. The researchers cut the network at its final convolutional layer, flattened the resulting feature maps, and passed them through a dense layer of 256 nodes connected to multiple output heads. Three classification heads predict patient sex, right ventricular systolic function category and right ventricular cavity size category, while a regression head outputs two continuous values: age and right ventricular end-diastolic diameter, the key linear measurement of chamber size taken at the moment the ventricle is most relaxed and full. Dropout layers between the dense connections help prevent the network from simply memorizing its training data.

An interesting wrinkle in the training strategy is that the model was first pre-trained with an identical architecture but only a single regression output — age. This kind of auxiliary task forces the network to learn general features of cardiac anatomy and image quality before being asked to tackle the harder, more clinically specific problem of measuring the right ventricle. It is a form of curriculum learning: master the easy, ubiquitous signal first, then refine toward the target measurement. The team also leveraged RVENet, a large public echocardiographic dataset for right ventricular assessment, whose creators they explicitly credit in the paper.

Validation was deliberately broad. The researchers tested DROID-RV in 9,112 patients drawn from primary care — a very different population from the cardiology clinics where the training data came from — and in 831 patients whose right ventricular ejection fraction had been measured by three-dimensional echocardiography, a more demanding and quantitative technique that is rarely used in routine practice. Across these test samples, the model accurately estimated right ventricular end-diastolic diameter and correctly identified right ventricular systolic dysfunction. The authors are candid about the model’s limits: prediction error grows at the extremes of right ventricular size and function, precisely where the most abnormal hearts live and where clinical judgment matters most.

Why has the right ventricle been so hard to measure in the first place? Unlike the thick-walled, bullet-shaped left ventricle, the right ventricle is a thin-walled, crescent-shaped structure wrapped around the left side of the heart. Its complex geometry defies the simple prolate-ellipse assumptions that make left ventricular volume estimation relatively straightforward from two-dimensional images. Professional guidelines acknowledge the problem, and prior studies have documented poor interobserver concordance even among experienced echocardiographers asked to grade right ventricular size and systolic function. Measurements that vary from reader to reader are measurements that vary from lab to lab — and that undermines their prognostic value.

This is where the deep learning approach changes the calculus. A neural network applies exactly the same visual criteria to every clip it sees, producing measurements with perfect reproducibility even if its absolute accuracy is bounded by the quality of two-dimensional imaging. The team demonstrated this consistency using saliency maps based on gradient-weighted class activation mapping, a technique that highlights the image regions driving the network’s predictions. The saliency videos published with the paper show the model focusing on the right ventricular free wall and cavity in ways that correspond to how a trained sonographer would assess dilation and hypokinesis — evidence that the network learned anatomically meaningful features rather than exploiting spurious correlations.

The most consequential finding, however, is prognostic. When the researchers stratified patients by the model’s predicted right ventricular size and function, they observed clear differences in the cumulative incidence of major outcomes: mortality, incident atrial fibrillation and incident heart failure all clustered according to the AI’s assessment of this one chamber. This aligns with a growing body of literature linking right ventricular ejection fraction to major adverse cardiovascular events and linking right ventricular structure to new-onset atrial fibrillation, but it extends those associations to predictions generated automatically, at scale, from standard two-dimensional scans that already exist in electronic health records by the hundreds of thousands.

The work also fits into a broader arc of cardiovascular AI research from the same ecosystem. Previous efforts from this group showed that deep learning assessment of left heart structure and function predicts cardiovascular outcomes, and other teams have demonstrated video-based AI for beat-to-beat assessment of cardiac function and automated interpretation of systolic and diastolic performance. What distinguishes the new study is its focus on the right side of the heart — the chamber that two-dimensional echocardiography handles worst — and its dual validation strategy spanning both a general primary care population and a three-dimensional echocardiography reference standard. The researchers followed reporting guidelines for observational studies and for machine learning evaluation in cardiovascular imaging, and they used natural language processing methods previously validated for cohort construction in electronic health records.

The practical implications are striking. Because the model runs on standard transthoracic echo videos, it could in principle retrofit quantitative right ventricular assessment onto the enormous existing archive of echocardiograms, extracting prognostic information from studies performed years ago without a single new scan. The team has released model code and data processing scripts through the Broad Institute’s machine learning for health repository, along with synthetic test data demonstrating the training and inference pipelines, and limited de-identified source data sufficient to recreate the published figures. Real clinical deployment will require prospective validation, regulatory review and careful attention to the model’s degraded performance at the extremes of right ventricular pathology — but the direction of travel is unmistakable. An measurement that was once subjective, inconsistent and often skipped can now be generated automatically for every patient, every study, every time. And as this study shows, that measurement carries real information about who will live, who will develop atrial fibrillation, and who will develop heart failure. The forgotten chamber of the heart has finally found its voice, and it is speaking through the mathematics of deep neural networks.

Subject of Research: Deep learning assessment of right ventricular size and function from echocardiography for cardiovascular risk prediction

Article Title: Deep learning-enabled assessment of right ventricular size and function is associated with cardiovascular outcomes

Article References: Al-Alusi, M. A., Kopparapu, K., Singh, P., di Achille, P., Reeder, C., Lau, E. S., Shnitzer, T., Andrews, C. T., Kany, S., Rämö, J. T., Haimovich, J. S., Khurshid, S., Picard, M. H., Ho, J. E., Batra, P., Maddah, M., Lubitz, S. A., & Ellinor, P. T. (2026). Deep learning-enabled assessment of right ventricular size and function is associated with cardiovascular outcomes. Nature Cardiovascular Research. https://doi.org/10.1038/s44161-026-00886-4

Image Credits: AI Generated

DOI: 10.1038/s44161-026-00886-4

Keywords: deep learning, echocardiography, right ventricle, cardiovascular outcomes, artificial intelligence, medical imaging, heart failure, atrial fibrillation, risk prediction, cardiology, neural networks, Nature Cardiovascular Research